APA (7th ed.) Citation

Taylor, R., Basaly, V., Kong, B., Yang, I., Brinker, A. M., Capece, G., . . . Guo, G. L. (2024). Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse model. Toxicological Sciences, 202(2), 179. https://doi.org/10.1093/toxsci/kfae110

Chicago Style (17th ed.) Citation

Taylor, Rulaiha, et al. "Effects of Therapeutically Approved Individual Bile Acids on the Development of Metabolic Dysfunction-associated Steatohepatitis a Low Bile Acid Mouse Model." Toxicological Sciences 202, no. 2 (2024): 179. https://doi.org/10.1093/toxsci/kfae110.

MLA (9th ed.) Citation

Taylor, Rulaiha, et al. "Effects of Therapeutically Approved Individual Bile Acids on the Development of Metabolic Dysfunction-associated Steatohepatitis a Low Bile Acid Mouse Model." Toxicological Sciences, vol. 202, no. 2, 2024, p. 179, https://doi.org/10.1093/toxsci/kfae110.